Research output per year
Research output per year
- 25 results
Search results
-
2016
Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
Walsh, G. M., 2016, In: Expert Review of Clinical Immunology . 13, 2, p. 143-149 7 p.Research output: Contribution to journal › Literature review › peer-review
26 Citations (Scopus) -
2015
Mepolizumab based therapy in Asthma – an update
Walsh, G. M., 1 Aug 2015, In: Current Opinion in Allergy and Clinical Immunology. 15, 4, p. 392-396 5 p.Research output: Contribution to journal › Literature review › peer-review
23 Citations (Scopus) -
Anti-IL-4/-13 based therapy in Asthma
Walsh, G. M., 2015, In: Expert Opinion on Emerging Drugs. 20, 3, p. 349-352 4 p.Research output: Contribution to journal › Literature review › peer-review
27 Citations (Scopus) -
2014
Tralokinumab – anti IL-13 monoclonal antibody for treatment of asthma or idiopathic pulmonary fibrosis
Walsh, G. M., 2014, In: Drugs of the Future . 39, 3, p. 183-187 5 p.Research output: Contribution to journal › Literature review › peer-review
-
2013
Therapeutic Potential of Targeting Interleukin 5 in Asthma
Walsh, G. M., 1 Dec 2013, In: BioDrugs. 27, 6, p. 559-563 5 p.Research output: Contribution to journal › Literature review › peer-review
7 Citations (Scopus) -
An update on biologic-based therapy in asthma
Walsh, G. M., Nov 2013, In: Immunotherapy. 5, 11, p. 1255-1264 10 p.Research output: Contribution to journal › Literature review › peer-review
20 Citations (Scopus) -
Eosinophil Apoptosis and Clearance in Asthma
Walsh, G. M., 17 Apr 2013, In: Journal of Cell Death. 6, p. 17-25 9 p.Research output: Contribution to journal › Literature review › peer-review
Open AccessFile35 Citations (Scopus)6 Downloads (Pure) -
2012
Antagonism of cytokine-induced eosinophil accumulation in asthma
Walsh, G. M., 22 Nov 2012, In: Frontiers in Pharmacology. 3, 3 p., 197.Research output: Contribution to journal › Literature review › peer-review
Open AccessFile3 Citations (Scopus)6 Downloads (Pure) -
An update on emerging drugs for asthma
Walsh, G. M., Mar 2012, In: Expert Opinion on Emerging Drugs. 17, 1, p. 37-42 6 p.Research output: Contribution to journal › Literature review › peer-review
File18 Citations (Scopus)2 Downloads (Pure) -
2011
Novel cytokine-directed therapies for asthma
Walsh, G. M., 2011, In: Discovery Medicine. 11, 59, p. 283-91 9 p.Research output: Contribution to journal › Literature review › peer-review
20 Citations (Scopus) -
2009
Mepolizumab and eosinophil-mediated disease
Walsh, G. M., Dec 2009, In: Current Medicinal Chemistry. 16, 36, p. 4774-4778 5 p.Research output: Contribution to journal › Literature review › peer-review
28 Citations (Scopus) -
Novel therapies for asthma: advances and problems
Walsh, G. M., 2009, In: Frontiers in Medicinal Chemistry. 4, p. 688-706 19 p.Research output: Contribution to journal › Literature review › peer-review
-
2008
Emerging drugs for asthma
Walsh, G. M., Dec 2008, In: Expert Opinion on Emerging Drugs. 13, 4, p. 643-653 11 p.Research output: Contribution to journal › Literature review › peer-review
21 Citations (Scopus) -
A review of the role of levocetirizine as an effective therapy for allergic disease
Walsh, G. M., Apr 2008, In: Expert Opinion on Pharmacotherapy. 9, 5, p. 859-867 9 p.Research output: Contribution to journal › Literature review
10 Citations (Scopus) -
Recent developments in targeting eosinophil accumulation as a novel therapeutic approach for asthma
Walsh, G. M., Robinson, A. J. & Wu, P. W., 2008, In: The Open Allergy Journal . 1, p. 35-41 7 p.Research output: Contribution to journal › Literature review › peer-review
-
2006
Levocetirizine: an update
Walsh, G. M., 2006, In: Current Medicinal Chemistry. 13, 22, p. 2711-2715 5 p.Research output: Contribution to journal › Literature review
29 Citations (Scopus) -
Targeting airway inflammation: Novel therapies for the treatment of asthma
Walsh, G. M., 2006, In: Current Medicinal Chemistry. 13, 25, p. 3105-3111 7 p.Research output: Contribution to journal › Literature review
34 Citations (Scopus) -
2005
Anti-inflammatory properties of antihistamines: an update
Walsh, G. M., Jul 2005, In: Clinical & experimental allergy. 5, 1, p. 21-25 5 p.Research output: Contribution to journal › Literature review › peer-review
20 Citations (Scopus) -
Novel therapies for asthma - Advances and problems
Walsh, G. M., 2005, In: Current Pharmaceutical Design. 11, p. 3027-3038 12 p.Research output: Contribution to journal › Literature review
29 Citations (Scopus) -
2000
Eosinophil apoptosis: Mechanisms and clinical relevance in asthmatic and allergic inflammation
Walsh, G. M., 2000, In: British Journal of Haematology. 111, p. 61-67 7 p.Research output: Contribution to journal › Literature review
55 Citations (Scopus) -
1999
Advances in the immunobiology of eosinophils and their role in disease
Walsh, G. M., 1999, In: Critical Reviews in Clinical Laboratory Sciences. 36, p. 453-496 44 p.Research output: Contribution to journal › Literature review
77 Citations (Scopus) -
1997
Human eosinophils: Their accumulation, activation and fate
Walsh, G. M., Jun 1997, In: British Journal of Haematology. 97, 4, p. 701-709 9 p.Research output: Contribution to journal › Literature review › peer-review
53 Citations (Scopus) -
Mechanisms of human eosinophil survival and apoptosis
Walsh, G. M., May 1997, In: Clinical & experimental allergy. 27, 5, p. 482-487 6 p.Research output: Contribution to journal › Literature review › peer-review
58 Citations (Scopus) -
1996
Human eosinophils: Apoptosis versus survival in the mediation of inflammation.
Dewson, G., Wardlaw, A. & Walsh, G. M., 1996, In: Apoptosis. 1, p. 111-118Research output: Contribution to journal › Literature review › peer-review
5 Citations (Scopus) -
1994
MECHANISMS OF EOSINOPHIL AND BASOPHIL MIGRATION
WARDLAW, A. J., Walsh, G. M. & SYMON, F. A., Dec 1994, In: Allergy. 49, 10, p. 797-807 11 p.Research output: Contribution to journal › Literature review › peer-review
35 Citations (Scopus)